Insights

Innovative Biotech Collaborations Abolis Biotechnologies has established strategic partnerships with global leaders such as L'Oréal, EuroAPI, and HealthTech Bio Actives, demonstrating strong opportunities to supply sustainable biotech solutions to major corporations seeking eco-friendly ingredients and innovations.

Recent Funding Growth With a recent €35 million financing round and a €140 million alliance under the IPCEI Med4Cure program, Abolis shows significant financial backing, indicating potential capacity for scaling operations and increasing its market penetration in the biotech industry.

Industry Focus & Market Expansion Abolis targets diverse industries including food, healthcare, cosmetics, and chemicals by leveraging micro-organisms and synthetic biology, suggesting sales opportunities across multiple sectors seeking sustainable manufacturing and innovative biotech solutions.

Sustainability Commitment The company's focus on renewable raw materials, reducing greenhouse gases, and securing supply chains aligns with current market trends toward sustainability, creating pathways for partners interested in eco-friendly and responsible production technologies.

Technological Sophistication Utilizing cutting-edge biotech research, synthetic biology, and AI-driven innovation, Abolis offers advanced, tailor-made solutions that appeal to companies looking to incorporate high-tech, sustainable modifications into their product development pipelines.

Abolis Biotechnologies Tech Stack

Abolis Biotechnologies uses 8 technology products and services including jsDelivr, cdnjs, Swiper, and more. Explore Abolis Biotechnologies's tech stack below.

  • jsDelivr
    Content Delivery Network
  • cdnjs
    Content Delivery Network
  • Swiper
    Javascript Libraries
  • Lodash
    Javascript Libraries
  • PHP
    Programming Languages
  • X-Content-Type-Options
    Web & Portal Technology
  • Google Analytics
    Web Analytics
  • Apache HTTP Server
    Web Servers

Abolis Biotechnologies's Email Address Formats

Abolis Biotechnologies uses at least 1 format(s):
Abolis Biotechnologies Email FormatsExamplePercentage
First.Last@abolis.frJohn.Doe@abolis.fr
50%
First.Last@abolis.frJohn.Doe@abolis.fr
50%

Frequently Asked Questions

Where is Abolis Biotechnologies's headquarters located?

Minus sign iconPlus sign icon
Abolis Biotechnologies's main headquarters is located at Bâtiment 6, Genopole Campus 1, 5 Rue Henri Desbruères Evry, 91030, FR. The company has employees across 3 continents, including EuropeAsiaNorth America.

What is Abolis Biotechnologies's official website and social media links?

Minus sign iconPlus sign icon
Abolis Biotechnologies's official website is abolis.fr and has social profiles on LinkedInCrunchbase.

What is Abolis Biotechnologies's SIC code NAICS code?

Minus sign iconPlus sign icon
Abolis Biotechnologies's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Abolis Biotechnologies have currently?

Minus sign iconPlus sign icon
As of October 2025, Abolis Biotechnologies has approximately 59 employees across 3 continents, including EuropeAsiaNorth America. Key team members include Head Of Business Development, North America: F. S.Head Of Scientific Business Development: T. C.Head Of Software Development & It: Z. M. O.. Explore Abolis Biotechnologies's employee directory with LeadIQ.

What industry does Abolis Biotechnologies belong to?

Minus sign iconPlus sign icon
Abolis Biotechnologies operates in the Biotechnology Research industry.

What technology does Abolis Biotechnologies use?

Minus sign iconPlus sign icon
Abolis Biotechnologies's tech stack includes jsDelivrcdnjsSwiperLodashPHPX-Content-Type-OptionsGoogle AnalyticsApache HTTP Server.

What is Abolis Biotechnologies's email format?

Minus sign iconPlus sign icon
Abolis Biotechnologies's email format typically follows the pattern of First.Last@abolis.fr. Find more Abolis Biotechnologies email formats with LeadIQ.

When was Abolis Biotechnologies founded?

Minus sign iconPlus sign icon
Abolis Biotechnologies was founded in 2014.
Abolis Biotechnologies

Abolis Biotechnologies

Biotechnology ResearchFrance51-200 Employees

Abolis is a French company delivering high-impact innovations in biotechnologies. We provide tailor-made industrial solutions based on micro-organisms.
Founded in 2014, Abolis is made up of a team of 66+ people. Determined to become a key player in the transformation of manufacturing, we reinvent the future of numerous industries - from food to healthcare, cosmetics and chemicals.
We rely on biotechnologies and the untapped potential of micro-organisms to develop new solutions economically viable.  
We take up the industry's current challenges by: 
·      Using renewable raw materials 
·      Relocate essential production and secure supply chains
·      Reducing greenhouse gas emissions 

Because each customer has its own unique story and challenges, we cultivate a multidisciplinary, tailor-made approach. Science, economics, intellectual property, industrial realities: each of our answers is based on the best possible practices. 
We are…
independent in thought and action
rigorous in our approach and the way we work
creative because we never stop innovating, while remaining pragmatic
ambitious because we are passionate and determined to make a difference

Section iconCompany Overview

Headquarters
Bâtiment 6, Genopole Campus 1, 5 Rue Henri Desbruères Evry, 91030, FR
Website
abolis.fr
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2014
Employees
51-200

Section iconFunding & Financials

  • $1M

    Abolis Biotechnologies's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $1M

    Abolis Biotechnologies's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.